Chemoinformaics analysis of Methyl propionate
| Molecular Weight | 88.106 | nRot | 1 |
| Heavy Atom Molecular Weight | 80.042 | nRig | 1 |
| Exact Molecular Weight | 88.0524 | nRing | 0 |
| Solubility: LogS | -2.33 | nHRing | 0 |
| Solubility: LogP | 2.468 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 13.6183 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.566 |
| Synth | 1.64 |
| Natural Product Likeliness | 0.086 |
| NR-PPAR-gamma | 0.102 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.016 |
| HIA | 0.002 |
| CACO-2 | -4.563 |
| MDCK | 0.000031 |
| BBB | 0.999 |
| PPB | 0.871972 |
| VDSS | 0.719 |
| FU | 0.223883 |
| CYP1A2-inh | 0.83 |
| CYP1A2-sub | 0.715 |
| CYP2c19-inh | 0.17 |
| CYP2c19-sub | 0.107 |
| CYP2c9-inh | 0.17 |
| CYP2c9-sub | 0.642 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.148 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.092 |
| CL | 7.818 |
| T12 | 0.266 |
| hERG | 0.089 |
| Ames | 0.016 |
| ROA | 0.035 |
| SkinSen | 0.544 |
| Carcinogencity | 0.129 |
| EI | 0.935 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.984927 |